
Sign up to save your podcasts
Or
Today on the show, I’m joined by Michael Montalto, vice president of precision medicine at Amgen. Amgen is widely recognized as one of the most successful pharmaceutical companies in translating research and development into approved therapies. A key part of that success comes from their focus on precision medicine, and Mike brings a unique perspective from the forefront of that work.
TPM E48 highlights >
Episode 48 links:
4.7
77 ratings
Today on the show, I’m joined by Michael Montalto, vice president of precision medicine at Amgen. Amgen is widely recognized as one of the most successful pharmaceutical companies in translating research and development into approved therapies. A key part of that success comes from their focus on precision medicine, and Mike brings a unique perspective from the forefront of that work.
TPM E48 highlights >
Episode 48 links:
418 Listeners
43,440 Listeners
9,284 Listeners
110,845 Listeners
316 Listeners
61 Listeners
5,418 Listeners
9,243 Listeners
30 Listeners
1,161 Listeners